Diabetes Care
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Extract Freely available
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Fukui, M.
Right arrow Articles by Yoshikawa, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fukui, M.
Right arrow Articles by Yoshikawa, T.
Social Bookmarking
Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?
Diabetes Care 25:1900-1901, 2002
© 2002 by the American Diabetes Association, Inc.

Letters: Comments and Responses
Letter

Response to Öncül

Insulin sensitivity in patients with chronic hepatitis C virus infection

Michiaki Fukui, MD, Yoshihiro Kitagawa, MD, Naoto Nakamura, MD and Toshikazu Yoshikawa, MD

1 From the First Department of Internal Medicine, Kyoto Prefectural University of Medicine, Kyoto, Japan

We read with great interest the recent letter from Öncül et al. (1) reporting the correlation of serum leptin levels with insulin sensitivity in patients with chronic hepatitis C virus (HCV) infection. Their findings showed that fasting serum insulin levels and serum leptin levels were significantly elevated in patients with chronic HCV infection compared with control subjects and that fasting serum leptin and insulin levels and homeostasis model assessment–estimated insulin sensitivity were correlated in the whole group. Öncül et al. concluded that HCV infection may serve as an additional risk factor for the development of type 2 diabetes due to insulin resistance and hyperleptinemia.

Certainly, insulin resistance plays an important role for the development of type 2 diabetes in patients with chronic HCV infection because levels of fasting serum C-peptide were significantly more elevated in non–insulin-treated diabetic patients with (n = 18) than in those without (n = 72) HCV infection (0.73 ± 0.27 vs. 0.57 ± 0.27 nmol/l; P = 0.0321) who were matched by BMI. The authors should show the correlation of serum leptin levels with insulin sensitivity not in the whole group but only in patients with chronic HCV infection, and should exclude the effect of BMI to demonstrate the correlation of serum leptin levels with insulin sensitivity in patients with chronic HCV infection. Conversely, elevated levels of serum leptin and insulin resistance might be correlated regardless of HCV infection (2). Contrary to the conclusion by Öncül et al., that HCV infection may serve as an additional risk factor for the development of type 2 diabetes due to insulin resistance and hyperleptinemia, there are some reports that leptin reverses insulin resistance (3,4). Elevated levels of serum leptin in patients with chronic HCV infection were compatible with previous data (5), although the reason was not fully determined. The mechanism of insulin resistance in patients with chronic HCV infection may be due to decreased liver carbohydrate metabolism and hypersecretion of insulin-resistant cytokines, such as interleukin-6 (6) and tumor necrosis factor (7), which have been shown to be elevated in patients with chronic HCV infection, most likely as a result of HCV-induced inflammation (8,9).

Footnotes

Address correspondence to Michiaki Fukui, First Department of Internal Medicine, Kyoto Prefectural University of Medicine, Kamigyo-ku, Kyoto 602-8566, Japan. E-mail: sayarinapm{at}hotmail.com.

References

  1. Öncül O, Top C, Cavuslu T: Correlation of serum leptin levels with insulin sensitivity in patients with chronic hepatitis-C infection (Letter). Diabetes Care 25: 937, 2002[Free Full Text]
  2. Ruige JB, Dekker JM, Blum WF, Stehouwer CD, Nijpels G, Mooy J, Kostense PJ, Bouter LM, Heine RJ: Leptin and variables of body adiposity, energy balance, and insulin resistance in a population-based study: the Hoorn Study. Diabetes Care 22: 1097–1104, 1999[Abstract/Free Full Text]
  3. Petersen KF, Oral EA, Dufour S, Befroy D, Ariyan C, Yu C, Cline GW, DePaoli AM, Taylor SI, Gorden P, Shulman GI: Leptin reverses insulin resistance and hepatic steatosis in patients with severe lipodystrophy. J Clin Invest 109: 1345–1350, 2002[Medline]
  4. Kamohara S, Burcelin R, Halaas JL, Friedman JM, Charron MJ: Acute stimulation of glucose metabolism in mice by leptin treatment. Nature 389: 374–377, 1997[Medline]
  5. Testa R, Franceschini R, Giannini E, Cataldi A, Botta F, Fasoli A, Tenerelli P, Rolandi E, Barreca T: Serum leptin levels in patients with viral chronic hepatitis or liver cirrhosis. J Hepatol 33: 33–37, 2000[Medline]
  6. Kern PA, Ranganathan S, Li C, Wood L, Ranganathan G: Adipose tissue tumor necrosis factor and interleukin-6 expression in human obesity and insulin resistance. Am J Physiol Endocrinol Metab 280: E745–E751, 2001[Abstract/Free Full Text]
  7. Bestard JP, Maachi M, Nhieu JT, Jardel C, Bruckert E, Grimaldi A, Robert JJ, Capeau J, Hainque B: Adipose tissue IL-6 content correlates with resistance to insulin activation of glucose uptake both in vivo and in vitro. J Clin Endocrinol Metab 87: 2084–2089, 2002[Abstract/Free Full Text]
  8. Malaguarnera M, Di Fazio I, Romeo MA, Restuccia S, Laurino A, Trovato BA: Elevation of interleukin 6 levels in patients with chronic hepatitis due to hepatitis C virus. J Gastroenterol 32: 211–215, 1997[Medline]
  9. Nelson DR, Lim HL, Marousis CG, Fang JW, Davis GL, Shen L, Urdea MS, Kolberg JA, Lau JY: Activation of tumor necrosis factor-alpha system in chronic hepatitis C virus infection. Dig Dis Sci 42: 2487–2494, 1997[Medline]

Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
 Diabetes CareHome page
O. Oncul, C. Top, and S. Cavuslu
Response to Fukui et al.
Diabetes Care, October 1, 2002; 25(10): 1901 - 1902.
[Full Text]

This Article
Right arrow Extract Freely available
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Fukui, M.
Right arrow Articles by Yoshikawa, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fukui, M.
Right arrow Articles by Yoshikawa, T.
Social Bookmarking
Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum